Gene: JPT1
Official Full Name: Jupiter microtubule associated homolog 1provided by HGNC
Gene Summary: Located in cytosol; intercellular bridge; and microtubule cytoskeleton. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22935 | JPT1 Knockout cell line (HeLa) | Human | JPT1 | 1:3~1:6 | Negative | Online Inquiry |
KO22936 | JPT1 Knockout cell line (HCT 116) | Human | JPT1 | 1:2~1:4 | Negative | Online Inquiry |
KO22937 | JPT1 Knockout cell line (HEK293) | Human | JPT1 | 1:3~1:6 | Negative | Online Inquiry |
KO22938 | JPT1 Knockout cell line (A549) | Human | JPT1 | 1:3~1:4 | Negative | Online Inquiry |
JPT1 Gene Knockout Cell Lines are specifically engineered cellular models that have undergone precise genetic modifications to disable the expression of the JPT1 gene. This product offers researchers valuable insights into the biological functions associated with JPT1 and its implications in various cellular processes and disease mechanisms. By employing CRISPR/Cas9 technology or similar gene editing techniques, these knockout cell lines provide an unparalleled platform for studying gene function, protein interactions, and cellular pathways.
The primary function of JPT1 Gene Knockout Cell Lines is to eliminate the JPT1 gene's activity, thereby enabling researchers to observe the resultant phenotypic changes. This knockout model facilitates the investigation of molecular mechanisms underlying various cellular processes, including differentiation, apoptosis, and response to stimuli, thus providing a critical tool for understanding disease pathways and potential therapeutic targets. The absence of JPT1 allows for a cleaner analysis of compensatory mechanisms or alternate pathways activated in response to the gene's loss.
Scientifically, these cell lines are pivotal in both research and clinical settings. Their application spans drug discovery, cancer research, immunology, and regenerative medicine, as they can be utilized to identify potential biomolecules that could be targets for pharmacological intervention or to explore the impact of JPT1 on cell behavior in disease models. The ability to discern the role of JPT1 in pathophysiology underscores its significance in advancing our understanding of complex biological systems.
Compared to alternative solutions, JPT1 Gene Knockout Cell Lines exhibit specific advantages, including high reproducibility, ease of use, and the capacity to provide clear experimental outcomes. Unlike transient knockdown methods, the stable knockout ensures persistent disruption of JPT1 expression, leading to more reliable and long-term studies. Additionally, researchers benefit from the well-characterized backgrounds of these cell lines, which enhance the reliability of experimental data.
For researchers and clinicians, these knockout cell lines are indispensable tools that enhance their investigative capabilities. By elucidating the biological roles of JPT1, users can drive innovation in treatment strategies and enhance the development of targeted therapies.
Our company prides itself on our expertise in genetic engineering and cell line development, providing robust biological products designed to accelerate scientific discovery. With JPT1 Gene Knockout Cell Lines, we commit to supporting your research needs and advancing the frontiers of biotechnology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.